Patent details

EP2512486 Title: NESTORONE®/ESTRADIOL TRANSDERMAL GEL

Basic Information

Publication number:
EP2512486
PCT Application Number:
US2010060941
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107992042
PCT Publication Number:
WO2011084668
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NESTORONE®/ESTRADIOL TRANSDERMAL GEL
French Title of Invention:
GEL TRANSDERMIQUE CONTENANT NESTORONE®/ESTRADIOL
German Title of Invention:
NESTORONE®/ESTRADIOL TRANSDERMALES GEL
SPC Number:

Dates

Filing date:
17/12/2010
Grant date:
28/06/2017
EP Publication Date:
24/10/2012
PCT Publication Date:
14/07/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/06/2017
EP B1 Publication Date:
28/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/12/2017
Expiration date:
17/12/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/06/2017
 
 

Name:
Antares Pharma IPL AG
Address:
Baarerstrasse 95, 6301 Zug, Switzerland (CH)

Name:
THE POPULATION COUNCIL, INC.
Address:
One Dag Hammarskjold Plaza, New York, NY 10017, United States (US)

Inventor

1

Name:
GRENIER, Arnaud
Address:
France (FR)

2

Name:
SITRUK-WARE, Regine
Address:
United States (US)

3

Name:
CARRARA, Dario Norberto, Ramon
Address:
Switzerland (CH)

Priority

Priority Number:
287514 P
Priority Date:
17/12/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 31/565; A61K 31/57; A61P 15/18;

Publication

European Patent Bulletin

Issue number:
201726
Publication date:
28/06/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/04/2018 Outgoing Correspondence 1